Pediatric Oncology Flashcards

To prepare for College Exam

1
Q

What is Tumor lysis syndrome (TLS)?

A

Deftn: Acute, life-threatening disease among children that is associated with the initiation of cytoreductive therapy in the treatment of malignancy.

Characteristic findings:

Raised: hyperuric acid, phosphate, K+, urea

Low: Ca+hypocalcemia, and uremia

Cplxns: cardiac arrhythmia, seizures, renal failure,

and sudden death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the Diagnostic Criteria for TLS

(Cairo Bishop grading for Lab & Clinical TLS)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the Cairo-Bishop Grading of Clinical Tumor Lysis Syndrome (TLS)?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do Allopurinol and Rasburicase work?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the CLINICAL FEATURES of TLS?

A

Timing:

  • Within 12 to 72 > initiation of cytotoxic therapy
  • Can occur < therapy (spontaneous) or extend > 72 hrs

Symptoms include:

nausea, vomiting, diarrhea, anorexia, weakness, lethargy,

hematuria, muscle cramps, tetany, and syncope.

Cplxns:
Cardiac dysrhythmias, seizures, sudden death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathogenesis- Hyperuricemia

A

Hyperuricemia with hyperphosphatemia, can lead to acute kidney injury.

Mecanism:

-Purine containing nucleic acids released

into the serum are catabolized to uric acid and, when

present in excess, surpass the renal tubular capacity for uric

acid excretion.

-Uric acid is poorly soluble in water, and the solubility is markedly reduced in the physiologically acidic environment of the distal tubules and collecting system. Thus, uric acid crystals readily precipitate when concentrated in the renal circulation, leading to renal tubule obstruction and obstructive uropathy, with compromised glomerular filtration and reduced

urine output.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does Allopurinol work?

A

Allopurinol blocks uric acid synthesis leading

to accumulation of the uric acid precursors xanthine and

hypoxanthine, of which hypoxanthine is more soluble and

more easily excreted than uric acid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does Rasburicase work?

A

-Urate oxidase oxidizes uric acid to the water-soluble and

readily excreted metabolite allantoin.

  • Rasburicase (urate oxidase) reduces uric acid levels without

increasing the levels of uric acid precursors, and therefore

does not risk xanthine nephropathy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the role of Hyperphosphatemia and Hypocalcemia in TLS?

A
  • Tumor cells have higher (PO4) than their normal cells
  • In TLS renal tubular excretion of (PO4) becomes saturated. - excess serum phosphate
  • Excess (PO4) binds to Ca+– low (Ca) + Ca PO4 deposition - - Low (Ca) Sx:
  • Arrythmias, seizures, Nephrocalcinosis -renal tubulular nephrolithiasis and cause or further provoke an obstructive

uropathy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Role of high K+ in TLS?

A

K+ is an ICF electrolyte regulated through renal excretion.

TLS HR K+ …cardiac dysrhythmias and sudden death.

Ca+ stabilizes the cardiac membrane, Low Ca+ exacerbates HR Ca+- induced cardiotoxicity and cardiac dysrhythmias.

HR Ca+ > 7.0 mEq/L(hyperkalemic emergency) and can be potentiated by ongoing TLS, Low Ca+, and/or renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Role of Acute Renal Injury in TLS?

A

AKI - independent predictor of short + long-term TLS mortality

Mecnms:

Crystal-dependent and crystal-independent mechanisms.

  1. Crystal-dependent mechanisms
    - obstructive uropathy.
    - Decreased urinary outputcan result in volume overload and cardiac failure, which can exacerbate crystal precipitation.

Urine alkalinization to > pH 6.5 not in use now

2. Crystal-independent mechanisms

-loss of autoregulation, renal vasoconstriction,

and local inflammation

-Tumor lysis–induced hypercytokinemia can result in hypotension, systemic inflammation, and multiorgan failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the Risk factors in TLS?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Monitoring blood tests?

A
  • Get baseline analyte values prior to Rx:

uric acid, electrolytes, LDH, and creatinine,

HIGH RISK: every 4 to 6 hours

INTERMEDIATE RISK: every 6-8 hours

LOW RISK: every 24 hours

N.B.

  1. uric acid levels may remain normal in patients with an emerging TLS ON ALLOPURINOL
  2. For rasburicase, laboratories must develop

protocols to collect uric acid samples in prechilled tubes that

are placed immediately on ice and kept on ice throughout

rapid transport to the laboratory for immediate run on the

instrument to prevent rapid in vitro uric acid breakdown,

and a spuriously low assay result.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Role of hydration in TLS?

A
  1. Maintaining a high urine output with adequate hydration
    - most important aspect of TLS prevention and

management, because this improves renal perfusion and

glomerular filtration, and minimizes acidosis, all of which

serve to prevent the precipitation of uric acid and calcium

phosphate crystals in the renal tubules.

  1. intermediate-to-high risk & for established TLS: hyperhydration with NS to maintain equal

fluid balance and a high urine output.

  1. K+, PO4, and Ca+ should NOT be added to the hydration solution.
  2. Monitored Volume status to prevent volume overload, particularly in patients with renal failure or cardiac dysfunction, and diuretics may be necessary to maintain urine output.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the role of Allopurinol in TLS?

A

“Preferred prophylactic in low-to-intermediate risk patients”

  • *Limitations:**
    1. As it it does not break down preexisting uric acid, urate nephropathy can develop in the 3 days it takes to have a therapeutic effect. SO is NOT the preferred agent in the presence of hyperuricemia.

Furthermore, xanthine nephropathy must be considered in patients who develop TLS while receiving appropriate prophylactic therapy with allopurinol.

  1. allopurinol is excreted by the kidneys and must be dose reduced or discontinued in patients with renal insufficiency.
  2. hypersensitivity reactions have occurred. Asian populations have a higher frequency of the HLAallele, which is associated

with severe adverse cutaneous reactions with allopurinol

use.

  1. because allopurinol reduces purine degradation,

chemotherapeutic agents, such as 6-mercaptopurine

and azathioprine, must be dose reduced by 50% to 70%

when concurrently administered.

N.B. Any patient who develops TLS while receiving allopurinol prophylaxis should be switched to rasburicase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Role of Rasburicase in TLS?

What are the benefits and limitations of rasburicase?

A

Preferred prophylactic agent for patients at high risk for TLS and the treatment of choice for established TLS.

Benefits:

  1. rapidly reduces uric acid levels and breaks down deposits of uric
  2. Reduces PO4 + serum creat levels
  3. does not require renal dosing;

however, there is a risk for

Problems:

  1. severe hypersensitivity reactions (anaphylaxis)

particularly with repeat dosing

  1. contraindicated in pregnant/lactating F & G6PD Def’y , (severe hemolytic anemia) - Screen for G6PD
17
Q

How do you manage electrolytes problems in TLS?

A
  1. Px with HR K+ or HOCa+ -cardiac monit & lytes q 4hrly
    - K+ > 7-7.5 or or widening of QRS complex requires immediate intervention.9,10 Standard therapies to lower the potassium

Rx for HR K+:

a. loop diuretics, insulin and glucose, inhaled bagonists, polystyrene sulfate, and calcium gluconate for

symptomatic hyperkalemia or electrocardiographic changes.

b. hemodialysis.
2. Hyperphosphatemia is treated with phosphate

binders.

  1. The presence of secondary hypocalcemia can be

life-threatening and generally necessitates the use of

hemodialysis. Asymptomatic hypocalcemia should not be

treated with calcium administration because of the risk of

increasing calcium phosphate deposition in the rena

18
Q

What are the indication for hemodialysis in TLS?

A
  1. refractory volume overload
  2. AKI: oliguria or anuria,
  3. persistent HR K+, HR uric acid despite above measures
  4. hyperphosphatemia-induced symptomatic hypocalcemia, and a calcium phosphate product of greater than 70 mg2/dL

N.B. Prophylactic hemodialysis in patients at risk for TLS may be appropriate in the setting of preexisting renal disease or acute renal injury at presentation, and further studies are needed